Product News and Recalls

Cosmopolitan informs readers of FDA Yaz warning

An entry on the blog for Cosmopolitan warns readers of a recent announcement by the U.S. Food and Drug Administration that Yasmin, Yaz, Beyaz, Safyral, Ocella and other oral contraceptives containing the compound drospirenone carry up to three times the risk of potentially fatal blood clots compared to other birth control pills on the market.

The blog item emphasizes that pregnancy itself is also a risk factor for developing blood clots. It quotes the FDA as saying the risk of developing a blood clot from birth control is relatively low.

However, some women’s health advocates have criticized the FDA after an agency panel that met in December to evaluate the risks of pills with drospirenone voted narrowly to keep this type of birth control on the market. It was later revealed that several members of the panel had professional and financial ties to the pills’ manufacturer.

The blog lists some warning symptoms of blood clots, provided by the FDA. They include persistent leg pain, severe chest pain and shortness of breath. If you have these symptoms, the blog says, you should call your doctor.

See the blog entry here: